The aim of this study is to evaluate compliance, acceptability, gastrointestinal tolerance, nutrient intake, appetite, nutritional status, and safety of four new ready to drink ONS. This is a prospective, longitudinal, 28-day intervention study with a 1-day baseline period. During the intervention period, patients will receive one of the four ONS for 28 days alongside their routine diet.
Protocol Amendment History
3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-02-16; most recent amendment 2026-04-09.
Status change: Recruiting → Active, Not Recruiting2026-04-09
Status change: Active, Not Recruiting → Recruiting2024-02-23